DOI QR코드

DOI QR Code

Dapsone: a steroid-sparing drug for refractory immunoglobulin A vasculitis?

  • Suh, Jin-Soon (Department of Pediatrics, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2019.12.17
  • Accepted : 2020.02.28
  • Published : 2020.05.15

Abstract

Keywords

References

  1. Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 2010;69:798-806. https://doi.org/10.1136/ard.2009.116657
  2. Trnka P. Henoch-Schonlein purpura in children. J Paediatr Child Health 2013;49:995-1003. https://doi.org/10.1111/jpc.12403
  3. Audemard-Verger A, Terrier B, Dechartres A, Chanal J, Amoura Z, Le Gouellec N, et al. Characteristics and management of IgA vasculitis (Henoch-Schonlein) in adults: data from 260 patients included in a French multicenter retrospective survey. Arthritis Rheumatol 2017;69:1862-70. https://doi.org/10.1002/art.40178
  4. Crayne CB, Eloseily E, Mannion ML, Azerf SP, Weiser P, Beukelman T, et al. Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature. Pediatr Rheumatol Online J 2018;16:71. https://doi.org/10.1186/s12969-018-0285-2
  5. Lee KH, Hong SH, Jun J, Jo Y, Jo W, Choi D, et al. Treatment of refractory Henoch-Schonlein Purpura (HSP) with dapsone: a systematic review. Clin Exp Pediatr 2020 Feb 6 [Epub]. https://doi.org/10.3345/kjp.2019.00514.
  6. Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res 2014;306:103-24. https://doi.org/10.1007/s00403-013-1409-7
  7. Liang SE, Hoffmann R, Peterson E, Soter NA. Use of dapsone in the treatment of chronic idiopathic and autoimmune urticaria. JAMA Dermatol 2019;155:90-5. https://doi.org/10.1001/jamadermatol.2018.3715
  8. Fernandes TRMO, Jesus BN, Barreto TT, Pereira AA. Dapsone-induced agranulocytosis in patients with Hansen's disease. An Bras Dermatol 2017;92:894-7. https://doi.org/10.1590/abd1806-4841.20176649
  9. Choi SY, Hwang HY, Lee JH, Park JS, Jang MS. Severe dapsone hypersensitivity syndrome in a child. Korean J Pediatr 2013;56:260-4. https://doi.org/10.3345/kjp.2013.56.6.260
  10. Devarbhavi H, Raj S, Joseph T, Singh R, Patil M. Features and treatment of dapsone-induced hepatitis, based on analysis of 44 cases and literature review. Clin Gastroenterol Hepatol 2017;15:1805-7. https://doi.org/10.1016/j.cgh.2017.05.031